• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CenterWatch Monthly February 2009

CenterWatch Monthly February 2009

February 3, 2009
CenterWatch Staff

Japan’s Global CT Push Boosts CROs, EDC

Japan is making changes at every level of drug development—government, site, patient and sponsor—to improve the ease with which it can be included in global drug development programs. While sponsor companies still have to deal with aspects where Japan and the West fundamentally differ, inclusion of Japan in their global development programs has increased dramatically.

Maine Transparency Guidance Issued

The state of Maine has issued a guidance that includes changes to the first law in the U.S. to mandate public reporting of clinical trial results. The guidance comes only six months after the state of Maine implemented the law.

CROs Continue to Expand Eastward

Clinical research is taking off in Central and Eastern Europe (CEE) as the region with the largest number of global clinical trial initiations outside North America and Western Europe. However, CEE has plenty of room to grow in large countries, such as Russia and Ukraine, whose enormous clinical research potential has just begun to be tapped. In addition, there are still CEE countries farther East—many of which are former Soviet Republics—that are just beginning to conduct clinical research.

Eye On: Bacterial Infections

Despite dramatic advances in understanding and curbing the spread of infectious agents, as well as improvements in preventive vaccines and antibiotic therapy, bacterial infections remain a   major source of morbidity and mortality. Pneumococcal disease, causing pneumonia, sepsis, meningitis, otitis media (middle ear infection) and other serious infectious illnesses, is the leading vaccine-preventable cause of death in children under five years old, according to the World Health Organization.

To read the full articles for this issue or for more information on these and other breaking stories, please click here> for subscription information.

Upcoming Events

  • 15Apr

    Five Telltale Signs You’re Ready for an Electronic TMF System

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

  • 06May

    The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Clinical-Trial-Brainstorming

    FDA, Industry Tackle Problem of Including Older Adults in Trials

  • ClinicalTrialNetwork-360x240.png

    National Community-Based Research Network Would Improve Reach of Trials

  • Bottleneck-360x240.png

    Sites Face Trials Bottleneck After Pandemic, But Also Opportunities

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Genetic Research and IBC Oversight Requirements

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing